Introduction
Numerous studies carried out in the area of apoptosis in the past decade clearly suggest that failure to execute an apoptotic program is one of the critical steps and a common mechanism that promotes tumorigenesis (McDonnell and Korsmeyer, 1991; LaCasse et al., 1998; Jaattela, 1999) . Perturbation of apoptosis itself does not directly result in cell transformation but facilitates the accumulation of mutations that may lead to deregulation of oncogenes and/or tumor suppressors such as c-Myc, p53 (Korsmeyer, 1992) . These mutations in conjunction with enhanced proliferative capacity, reduced growth factor dependence or impaired differentiation lead to cell progression towards neoplasia. Interestingly, abnormal cell survival, as with deregulation of oncogenes or tumor suppressive genes, appears to facilitate and initiate tumorigenesis only in a distinct cell population at a certain developmental stage. For instance, constitutive expression of Bcl-2, despite its universal role in protection of various cell types from apoptosis, is associated predominantly with B-cell lymphomas, both in humans and in mouse transgenic models. In humans, high levels of Bcl-2 protein expression can be detected in most cases of follicular lymphomas, including the majority with t(14:18) chromosomal translocation and many without it (Pezzella et al., 1990; Seite et al., 1993) . In the mouse system, Em-Bcl-2 mice, whose transgene is driven by the Em enhancer, exclusively develop B-cell lymphoma, although these mice express similar levels of Bcl-2 in their T cells and the T cells are equally resistant to killing by diverse lymphotoxic agents both in vitro and in vivo (McDonnell et al., 1989; Strasser et al., 1993) .
This selective behavior of Bcl-2 is similar to oncogenes such as abl that proves to be highly tumorigenic only in pre-B cells and plasma cells, but not in mature B cells, as shown by three lines of Em-v-abl transgenic (Tg) mice generated in separate laboratories (Rosenbaum et al., 1990) . These, along with many other studies, suggest that different cell types vary remarkably in their susceptibility to oncogenesis caused by a specific genetic defect, underscoring the importance of investigating individually the oncogenic potential of a specific gene in the context of a whole organism.
Immediate early response gene X-1 (IEX-1), also known as IER3, p22/PRG1, Dif-2, or the mouse homologue gly96, is a stress-inducible gene (Charles et al., 1993; Kondratyev et al., 1996; Pietzsch et al., 1997; Schafer et al., 1999) . It can be rapidly and transiently induced in various cells by irradiation, viral infection, inflammatory cytokines, chemical carcinogens, growth factors, and hormones under the control of multiple transcription factors including NF-kB/rel, p53, Sp1, c-Myc, and Ap1 (Pietzsch et al., 1998; Schafer et al., 1998; Wu et al., 1998; Huang et al., 2002; Im et al., 2002) . In contrast to normal cells, many tumor cell lines examined express IEX-1 constitutively. Yet, whether or not it plays any role in tumorigenesis is unknown. IEX-1 can either positively or negatively regulate cell death or proliferation, probably owing to its dual role in the extra-regulated kinase (ERK) signaling by acting both as a specific substrate for ERK and a regulator for ERK activation (Garcia et al., 2002) . Through the ERK signaling pathway that crosstalks with a variety of ubiquitous or lineage-restricted transcription factors, phosphorylation regulators and effectors, IEX-1 can affect proliferation, differentiation, and survival of different cell types (Schaeffer and Weber, 1999; Ballif and Blenis, 2001 ). This once again stresses the need for understanding the role of IEX-1 in a specific cell type using an in vivo system. In vivo forced expression of IEX-1 protects T cells from apoptosis, as has been demonstrated using IEX-1-Tg mice that target IEX-1 expression specifically to lymphocytes by the Em enhancer . These transgenic mice develop a lupus-like autoimmune disease due to insufficient apoptosis of T cells, clearly suggesting an antiapoptotic effect of IEX-1 in peripheral T cells.
In the present study, IEX-1-Tg mice demonstrate a significantly high incidence of T-cell lymphomas in the spleen, as they age, providing for the first time unambiguous evidence of the role of IEX-1 in oncogenesis. Em-IEX-1 mice may help our understanding of development of peripheral T-cell lymphoma, a rare but incurable type of lymphoma.
Results

Development of T-cell lymphomas in the spleens of Em-IEX-1 mice
Constitutive expression of IEX-1 protects T cells from apoptosis, resulting in development of a lupus-like autoimmune disease in Em-IEX-1 mice . Since prolonged cell survival or inhibition of apoptosis can predispose to tumorigenesis by facilitating the insurgence of mutations, we assessed an oncogenic potential of IEX-1 in these Em-IEX-1 mice. A cohort of 57 Em-IEX-1 mice and 54 non-Tg littermates were monitored for signs of lymphoma for 23 months (Table 1) . Of 57 Em-IEX-1 mice, 24 showed remarked enlargement of the spleens that weigh from 392 to 980 mg with a mean of 659 mg, a more than sevenfold increase compared to age-matched control spleens (85-95 mg) (Figure 1) . Majority of the spleens exhibited foci of tan discoloration either throughout or part of their surface. Histological examination and flow cytometric analysis revealed malignant lymphomas in 20 out of the 24 mice with splenomegaly, at a mean age of 21 months, ranging from 16 to 23 months, including three mice that developed lymphomas both in the lymph nodes (LNs) and in the spleen ( Table 1) . Five of them also presented with a rapidly expanding abdominal cavity full of tumoral ascites, representative of a late-phase lymphoma development. Since these mice were terminally ill, they were autopsied prior to the full monitoring period (23 months). Intriguingly, only two mice developed lymphoma in the LNs without accompanying malignancy in the spleens. Thymic hyperplasia was not seen in the entire cohort of Em-IEX-1 mice. These observations suggest a primary site of lymphoma development in the spleen. The cohort of transgenic mice included two independent lines of Em-IEX-1 mice derived from founder 2 and 4, respectively . There is no statistic significance in the frequency of malignant lymphoma or splenomegaly between these two lines of transgenic mice, ruling out the possibility that the observed lymphomas in Em-IEX-1 mice resulted from the insertional effects of the transgene. The results of these two independent transgenic lines are thus presented together.
In agreement with our previous findings that IEX-1 overexpression protected T but not B cells from apoptosis , 20 out of the 22 lymphomas were of T-cell origin, as evidenced by positive staining of anti-CD3 antibody (Ab). Single-
, and double-positive (CD4 þ CD8 þ ) T cells were identified in these T-cell lymphomas (Table 1) . These double positive or double negative T cells unlikely developed from thymocytes, as no abnormality of 20/57 CD3+CD4+CD8-CD3+CD4+CD8- (7) CD3+CD4ÀCD8+ (5) CD3+CD4+CD8+ (6) CD3+CD4ÀCD8-(2) Other tumours 3.7% (2/54, liver and lung) 5% (3/57, kidney, intestine and stomach) a Splenomegaly, the spleens were enlarged by X four fold in weight compared to normal spleens. b Lymphomas were characterized by FACS analysis using anti-CD3, and anti-B220 antibodies. T-cell Lymphomas were further analysed by anti-CD3, anti-CD4, and anti-CD8 antibodies. The numbers in parentheses indicate the number of mice involved. LN, lymph node
Oncogenic potential of anti-apoptotic gene IEX-1 Y Zhang et al thymocyte development was seen in the animal. Total numbers of thymocytes and percentages of single-
, and double-negative (CD4
) thymocytes were statistically indistinguishable between transgenic and nontransgenic littermates (data not shown) . In sharp contrast to a high rate of T-cell lymphomas in Em-IEX-1 mice, only one mouse spontaneously developed T-cell lymphoma among 54 non-Tg control mice, despite the fact that five mice developed splenomegaly. The frequencies of spontaneous T-cell lymphoma and splenomegaly in our control mice are commonly seen in aged C57BL/6 mice. Not only is T-cell lymphoma development of great interest, the incidence of B-cell lymphoma development was indistinguishable between Tg and control mice. Only two B-cell lymphomas were seen in each group, which is clearly independent of IEX-1 expression. No lymphomagenesis was observed in the LNs of control mice. Additionally, five other tumors were found within the entire tumor watch cohort (one hepatocellular carcinoma, one lung tumor, one intestinal tumor, one stomach carcinoma, and one kidney carcinoma). They occurred randomly among Em-IEX-1 mice (three tumors) and non-Tg control mice (two tumors) ( Table 1) .
Development of T-cell lymphoma resulted in a complete or partial loss of normal architecture of the spleens in 20 out of the 57 IEX-Tg mice (Figure 2) . The red and the white pulp were often paler than normal and filled with uniform atypical lymphoid cells. Some of them showed numerous mitotic figures. The lymphomas from Em-IEX-1 mice are morphologically diverse, including small-cell, intermediate-cell and large-cell, or a mixture of small-cell and large-cell lymphomas (Figure 2 ). In small lymphocyte lymphoma, the spleens were composed of small-to medium-sized well-differentiated relatively uniform lymphocytes with a low mitotic index (D). In contrast, numerous mitotic figures were presented in the sections prepared from large-cell lymphoma (arrows, F), and several of them displayed immunoblastic features. T-cell lymphomas were further characterized by flow cytometric analysis of the T-cell receptor (TCR) repertoire using a panel of monoclonal Abs (mAbs) recognizing TCR Vb chain. Clonal expansions of a specific T-cell population like Vb2, Vb3, and Vb4 in Tg 22 mouse, Vb2 and Vb3 in Tg 27 mouse, and Vb3 in Tg 48 mouse, respectively, were clearly identified (Figure 3a) . Clonality of the lymphomas developed in Em-IEX-1 mice was also supported by a discrete pattern of TCR Jb2 gene rearrangements in Southern blot analysis (Figure 3b ). These results provide unambiguous evidence of the development of T-cell lymphomas in these mice at an incidence rate of 35%, a rate that is Hyperplastic white pulp is seen in the most part of the spleen with severe infiltration of lymphocytes in the red pulp. Only 5% of the spleen remains normal with more preserved around the edge. High mitotic rate is evident in some areas of both the white and red pulp (not shown). (f), A mixture of small-cell and large-cell lymphoma from the spleen of a 23-month-old Tg mouse. Note extensive infiltration and complete effacement of the entire spleen by atypical lymphoma and extremely high mitotic rate (arrows). The mouse also showed a rapidly expanding abdominal mass, ascites, and invasion of liver, intestine and stomach Oncogenic potential of anti-apoptotic gene IEX-1 Y Zhang et al comparable or higher than the lymphoma incidence rate of Lck-Bcl-2 mice (Linette et al., 1995) , which target Bcl-2 expression specifically to T cells driven by a T-cellspecific Lck promoter. The study clearly demonstrates the oncogenic potential of IEX-1.
Phosphorylation of IEX-1 occurs in T cells from Em-IEX-1 mice
In previous studies, we showed similar levels of IEX-1 transcription in T and B cells from Em-IEX-1 mice . It has however been a great debate that mRNA levels may not reflect the levels of their protein expression in many cases. In particular, IEX-1 encodes a polypeptide of approximately 18 kDa that is known to be extensively modified by post-translational mechanisms such as glycosylation or phosphorylation (Charles et al., 1993; Garcia et al., 2002) . To determine whether different effects of IEX-1 on the survival of T and B cells resulted from IEX-1 protein levels or posttranslational modifications, we examined IEX-1 protein expression in T and B cells from Em-IEX-1 mice. As shown in Figure 4a , B cells from Em-IEX-1 mice expressed IEX-1 protein at levels indistinguishable from T cells, with a predominant form of a 29 kDa and a minor unmodified IEX-1. IEX-1 protein was not detected in the cells isolated from non-Tg mice, indicating a specificity of the anti-IEX-1 Ab used. Apparently, the ability of IEX-1 to protect T but not B cells from apoptosis induced by the ligation of Fas is Recent studies show that IEX-1 can be phosphorylated by ERK1/2 both in vivo and in vitro and the phosphorylation is required for antiapoptosis activity of IEX-1 (Garcia et al., 2002) . To determine whether IEX-1 phosphorylation status differed between T and B cells in Em-IEX-1 mice, we studied IEX-1 phosphorylation in T and B cells isolated from Em-IEX-1 mice at 6-8 weeks of age, prior to development of any sign of splenomegaly or autoimmune disease, so that T and B cells be compared at nonactivation stage . Tand B-cell lysates were immunoprecipitated by anti-IEX-1 Ab and the precipitated proteins were subjected to Western blotting analysis using affinity-purified antiphosphoIEX-1 Ab that was made against the ERKphosphorylation site (T18) of IEX-1 (Garcia et al., 2002) . As shown in Figure 4b , IEX-1 phosphorylation was detected in T cells but not B cells from Em-IEX-1 mice (top panel, lane 2 vs. 4), although similar amounts of IEX-1 protein were revealed in both B and T cells while anti-IEX-1 Ab was employed in immunoblotting (low panel). In some samples, a weak band could be seen in B cells after overexposure of the film, at levels significantly lower than in T cells. The increased phosphorylation of IEX-1 in T cells compared to B cells probably explains protective effects of IEX-1 against apoptosis in a cell-type-specific fashion in the animal.
Discussion
Tg mouse models have proved to be an invaluable resource for determining an oncogenic potential of a given gene by revealing the consequences of its deregulation in the most relevant context, namely the living animal with an appropriate choice of regulatory elements. The impact of an oncogene investigated in a pertinent normal cell type rather than in cell lines is of particular importance for studying stress-inducible genes like IEX-1, as cell lines, unlike primary cells, have already adapted themselves to survive various stresses during a long period of cell culture and in addition are burdened by unknown and diverse mutational histories.
Studies have shown that overexpression of IEX-1 facilitates apoptosis in several cell lines under conditions of serum deprivation, as evidenced by typical apoptotic morphological changes and increases in caspase-3 activity Grobe et al., 2001; Schilling et al., 2001) . For instance, HeLa cells exhibited only a moderate apoptotic response when treated with TNF-a or upon the ligation of Fas. The apoptotic response was however significantly increased in the presence of ectopic IEX-1 . On the contrary, recent studies indicate that IEX-1 interacts with phosphorylated ERKs and can be in turn phosphorylated by the associated ERKs (Garcia et al., 2002) . Upon phosphorylation, IEX-1 acquires the ability to inhibit cell death induced by various stimuli (Garcia et al., 2002) , in agreement with our previous studies demonstrating that IEX-1 was one of the NF-kB/relregulated genes for cell survival . In addition to sensitization to apoptosis, disruption of IEX-1 expression using anti-IEX-1 ribozymes that specifically cleave IEX-1 mRNA decreases the number of 293 and HeLa cells residing in G2 M phase Grobe et al., 2001) , suggesting a role for IEX-1 in the promotion of cell cycle (Kumar et al., 1998; Arlt et al., 2001) , which may be ascribed to its ability to enhance ERK activation in response to various growth factors (Garcia et al., 2002) . These varying effects of IEX-1 on cell survival and cycling may be a direct reflection of a dual role for IEX-1 in the ERK signaling.
Em-IEX-1 mice that target IEX-1 expression to both T and B lymphocytes under the control of the Em enhancer developed a relatively high incidence of a lupus-like autoimmune disease at age of 9-10 months and subsequently T-cell lymphomas in the spleens, as they aged further, strongly arguing for an antiapoptotic effect of IEX-1 on mature T cells . Consistent with this is a significant increase in the percentage and number of T cells in the periphery of Em-IEX-1 mice, whereas no alteration in the number of B cells was observed in IEX-1-Tg mice compared to nonTg control mice . Moreover, T cells from the transgenic mice underwent apoptosis at reduced levels in response to anti-CD3 or anti-Fas Ab treatment. Also, staphylococcal enterotoxin B (SEB) superantigen-induced depletion of peripheral T cells was decreased drastically in vivo in IEX-1-Tg mice compared to their control littermates. In contrast to T cells, B cells lanes 1 and 3) . The precipitated proteins were analysed by immunoblotting using either anti-phospho-IEX-1 Ab (top panel) or anti-IEX-1 Ab (low panel). One representative result of three experiments performed is shown Oncogenic potential of anti-apoptotic gene IEX-1 Y Zhang et al from Em-IEX-1 mice responded to the ligation of Fas indistinguishably from those in non-Tg control mice . Since IEX-1 expression levels in T and B cells from IEX-1-Tg mice are comparable, it is reasonable to ascertain a prominent role for IEX-1-mediated antiapoptotic function in T cells. Also, continued and forced expression of IEX-1 in both T and B cells appears to favor a high incidence of only Tcell lymphomas, once again reinforcing a selective role for IEX-1 in T cells. In accordance to this, phosphorylation of IEX-1 appears to occur in T cells at levels higher than in B cells in Em-IEX-1 mice. The observation is consistent with recent studies that IEX-1 phosphorylation is required for its antiapoptotic function, although other effects of IEX-1, such as promotion of cell cycling (Kumar et al., 1998; Arlt et al., 2001) , may also contribute to its oncogenic potential.
Similar to Lck-Bcl-2 mice, a substantial latency period is needed for histological conversion and transformation of T cells in Em-IEX-1 mice, implicating the involvement of secondary somatic changes (McDonnell and Korsmeyer, 1991) . In agreement with this, a relatively higher incidence of T-cell lymphomas was attained in Em-IEX-1 mice that had experienced a delayed-type hypersensitivity (DTH) response early in life compared to those without it. T cells in these mice were activated by three consecutive injections with heat-killed Mycobacterium tuberculosis at 2, 3, and 5 months of age, respectively, as described . Likewise, 10 out of 14 Em-IEX-1 mice that survived a lupus-like autoimmune disease developed T-cell lymphomas. Perhaps, a DTH response and autoimmunity involve extensive proliferation of T cells that, coupled with abnormal T-cell survival, predisposes to tumorigenesis, in light of the multistep lymphomagenesis model (Ghebranious and Donehower, 1998) .
Cell fate decisions in immunity represent a complex integration of signals delivered by antigen receptors, coreceptors, cytokines, and cell death surface receptor proteins. Thus, a specific population of lymphocytes at a certain developmental stage must survive through precisely regulated activities of individual antiapoptotic genes. While Bcl-2, Bcl-xL, A1, Mcl-1, and c-FLIP all have the ability to enhance cell survival, Em-Bcl-2-Tg mice independently derived from several laboratories show an increased incidence in B but not T-cell lymphoma (Katsumata et al., 1992; Strasser et al., 1993; Zhou et al., 2001; Chuang et al., 2002) . Moreover, A1 and Mcl-1, two members of the Bcl-2 family, both perturb B-cell development but have little effect on the homeostasis of T cells (Chuang et al., 2002) . These observations suggest that the members of the Bcl-2 family except for Bcl-xL affect homeostasis of B cells more than T cells while overexpressing (Grillot et al., 1995) . The same holds true for c-FLIP that causes accumulation of B cells not T cells in vivo, despite the fact that it protects both T and B cells from apoptosis induced by cell death receptors such as Fas (Van Parijs et al., 1999) . In marked contrast, we show here that IEX-1 selectively interferes with T-cell homeostasis and facilitates the development of T-cell lymphomas rather than B-cell lymphomas, providing a unique opportunity for our understanding the molecular basis of peripheral T-cell lymphoma development, a rare but incurable disease.
Materials and methods
Animals
IEX-1-Tg mice or Em-IEX-1 mice were generated by expression of human IEX-1 gene under the control of an immunoglobulin (Ig) heavy chain (m) enhancer that drives the expression of the transgene specifically in T-and B-cell lineages (Pircher et al., 1989; Zhang et al., 2002) . The animals were maintained at the animal facility of the Baylor College of Medicine in accordance with the college's guidelines. All animals were autopsied within 48 h of any overt signs of terminal illness or at 23 months of age. The spleens, LNs, and tumors were removed and processed for histological examination. Spleens or LNs showing gross morphological alteration were dissected into several pieces for fixation and preparation of single-cell suspension or frozen for subsequent analyses.
Flow cytometric analysis
To characterize the lymphomas developed in Em-IEX-1 mice, single-cell suspensions were prepared from hyperplastic spleens and LNs, fixed in 1% formaldehyde and stained with Abs specific for mouse T and B cells. Abs including fluorescein isothiocyanate (FITC)-conjugated anti-CD4, anti-CD8, antiIgM, and anti-CD3; phycoerythrin (PE)-conjugated anti-B220, and anti-CD8; biotin-conjugated anti-CD19; and cy-Chrome (CyC)-conjugated streptavidin were all purchased from PharMingen. The stained cells were analysed by FACScan cytometer (Becton-Dickinson) equipped with a Cellquest software. For analysis of clonal expansions of T cells by a Mouse Vb TCR screening kit (PharMingen), aliquots of lymphoma cell suspensions were stained with a panel of mAbs recognizing TCR Vb chain, including Vb 2, 3, 4, 5.1 and 5.2, 6, 7, 8.1 and 8.2, 8.3, 9, 10 b , 11, 12, 13, 14, and 17 a TCR as per the manufacturer's instruction.
Immunoprecipitation and Western blotting
Single-cell suspensions were prepared from Tg or control mouse LNs and spleens. T and B cells were purified by treatment of the cell suspension with a cocktail of rat antimouse Abs against CD32, CD19, or CD3, followed by depletion of Ab-bound cells with BioMag goat anti-rat IgG (Polysciences, Inc., PA, USA) as described (Wu et al., 1995) . The purified T and B cells were lysed in 50 mm Tris pH 7.5 buffer containing 137 mm NaCl, 1% Triton X-100, 10% glycerol, 1 mm EDTA, and a protease inhibitor cocktail (Sigma). For comparison of IEX-1 expression in T and B cells, approximately 100 mg of whole-cell lysate proteins was separated by SDS-PAGE, transferred onto a nitrocellulose membrane, and immunoblotted with an affinity purified polyclonal Ab recognizing specifically IEX-1, which was raised in rabbits against IEX-1 peptide sequence 51-75 (Feldmann et al., 2001) . IEX-1 proteins were detected by incubation of the membrane with horseradish peroxidase (HPR)-linked goat anti-rabbit Ab and development in SuperSignal West Pico Kit (PIERCE, IL). The same membranes were stripped and reprobed with anti-a-tubulin (Sigma, MI, USA) as protein loading controls.
To study IEX-1 phosphorylation, T and B cells were isolated as above and pooled from three to five mice. The cells were lysed in 50 mm Tris pH 7.5 buffer containing 137 mm NaCL, 1% Triton X-100, 10% glycerol, 1 mm EDTA, 1 mm orthovanadate, 25 mm b-glycerophosphate and a protease inhibitor cocktail (Sigma). The cell lysates were precleaned with protein A-coupled Sepharose beads. Immunoprecipitation (IP) was carried out with use of anti-IEX-1 Ab and protein A-coupled Sepharose beads. The precipitated proteins were subjected to immunoblotting analysis using antiphosphopeptide P-T18 (CMTILQAPp-TPAPSTI) (Garcia et al., 2002) or anti-IEX-1 Ab, respectively.
Histological examination
Spleens and LNs, with sign of gross morphological alteration and tumor tissues, were fixed with 10% formalin, embedded in paraffin, and sectioned at 4 mm. Sections were then stained with hematoxylin (H) and eosin (E) by standard methods and subjected to histological examination.
Southern blot analysis
DNA (10 mg) of individual lymphomas from Em-IEX-1 mice was digested with HindIII and analysed on Southern blots using a randomly primed probe that recognizes the entire TCR Jb2 gene segment as previously described (Malissen et al., 1984) .
